Keywords: gilead, 1st-qtr, sales, reach, 9m, up, usa-based
Gilead's 1st-qtr sales reach $692.9M, up 61%
Article | 15 May 2006
USA-based biotechnology company Gilead Sciences says that its total revenues for the quarter ended March 31, 2006, were $692.9 million, up 61% on the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Elan makes "transformational" acquisitions and a divestment
